Skip to content

Efficacy and Mechanism of Percutaneous Magnetic Stimulation Stellate Ganglion Block in the Treatment of Chronic Insomnia

Efficacy and Mechanism of Percutaneous Magnetic Stimulation Stellate Ganglion Block in the Treatment of Chronic Insomnia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500115102
Enrollment
Unknown
Registered
2025-12-22
Start date
2026-01-01
Completion date
Unknown
Last updated
2026-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Insomnia

Interventions

Ultrasound-guided stellate ganglion block group:1% lidocaine, 5ml, for stellate ganglion block
Percutaneous magnetic stimulation stellate ganglion block group:Repetitive 1 Hz magnetic stimulation of the stellate ganglion
Percutaneous sham stimulation of stellate ganglion block group:Pseudo-stimulation repeatedly stimulates the stellate ganglion

Sponsors

Henan Mental Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Outpatients or inpatients; meeting the diagnostic criteria for chronic insomnia disorder as defined in the International Classification of Sleep Disorders - Third Edition (ICSD-3); 2. Age range: 18 to 65 years old, stable vital signs, and no communication barriers; 3. with an educational level of primary school or above; 4.PSQI score of 7 before treatment; 5. the patient agrees to participate in the study and signs the informed consent form;

Exclusion criteria

Exclusion criteria: 1. Individuals with severe cardiovascular diseases, neurological disorders or other serious chronic illnesses; 2. Pregnant or lactating women; 3. Individuals who have allergic reactions to anesthetic drugs; 4. Those with chronic pain, restless legs syndrome, periodic limb movement disorder, obstructive sleep apnea, thyroid diseases, coagulation dysfunction, local skin infections, glaucoma, and patients with mental disorders who do not cooperate and diseases that affect cortisol secretion; 5. Those with a history of epilepsy or brain trauma; 6. Those with contraindications for magnetic resonance scanning or transcranial magnetic stimulation treatment, such as implanted cardiac pacemakers, cochlear implants, etc. 7. Pregnant women, lactating women, and those receiving hormone therapy; 8. Those who have not signed the informed consent form;

Design outcomes

Primary

MeasureTime frame
Sleep quality, sleep latency time, maintenance time, total sleep time;Sleep quality, sleep latency time, maintenance time, total sleep time;

Secondary

MeasureTime frame
Left hippocampus - superior parietal lobe functional connectivity changes;Anxiety, depression;cognitive;

Countries

China

Contacts

Public ContactYahui Xu

Henan Mental Hospital

18737354427@163.com+86 373 287 8328

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026